Complete Up To Date Information about Fura Ointment.
NADA Number: 100-854 | |
| Proprietary Name |
Fura Ointment |
|---|---|
| Sponsor |
Farnam Companies, Inc. |
| Sponsor Address |
301 West Osborn Phoenix, AZ 85013-3928 USA |
| Ingredients |
Nitrofurazone |
| Species |
Horse, not for meat production Dog, no use class stated or implied |
| Routes of Administration |
Topical |
| Dose Form |
Ointment |
| Drug Form |
Ointment |
| Dispensing Status |
OTC |
|
Dosage Amount, Indications & Limitations |
524.1580b Nitrofurazone ointment. Specifications: The drug contains 0.2 percent nitrofurazone in a water-soluble base. Conditions of use: Dogs Amount: Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period. Indications: For prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers of dogs or horses. Limitations. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness irritation, or swelling persists or increases, discontinue use. Consult veterinarian. Horses Amount: Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period. Indications: For prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers of dogs or horses. Limitations. Not for use in horses intended for food. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness irritation, or swelling persists or increases, discontinue use. Consult veterinarian. NAS/NRC status: These conditions are NAS/NRC reviewed and found effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information. |